Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, 06560, Turkey.
University of Health Sciences, Gulhane Faculty of Pharmacy, Department of Pharmaceutical Botany, Ankara, Turkey.
Talanta. 2025 Jan 1;282:127005. doi: 10.1016/j.talanta.2024.127005. Epub 2024 Oct 9.
This work represents the first successful application of a molecularly imprinted polymer (MIP)-based electrochemical sensor for the sensitive and selective determination of the first developed proteasome inhibitor, bortezomib (BOR). BOR is used for the treatment of multiple myeloma, gastrointestinal stromal tumors, and mantle cell lymphoma. It shows its desired effect through the boronate group and can be administered intravenously or subcutaneously. The MIP-based electrochemical sensor design includes the integration of green-synthesized saffron-based copper nanoflowers (CuNFs) from Crocus sativus L. to increase the active surface area and porosity of the glassy carbon electrode (GCE) surface. 2-Acrylamido-2-methyl-1-propanesulfonic acid (AMPS) was selected as the functional monomer along with other MIP components. Detailed characterizations of the developed CuNFs/AMPS/MIP-GCE sensor and CuNFs were performed using scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), energy dispersive X-ray analysis (EDX), cyclic voltammetry (CV), and electrochemical impedance spectroscopy (EIS). The indirect measurement approach using 5.0 mM [Fe(CN)] solution was used to determine BOR in the linear range of 2.5 × 10 M - 2.5 × 10 M (0.25-2.5 pM). The LOD and LOQ values of the sensor obtained at the fM level (29 fM and 96.7 fM), which has a linear response in the commercial human serum sample in the same concentration range, emphasize its sensitivity (1.89 × 10 and 2.14 × 10 μA/M for standard solution and serum). The repeatability and reproducibility of the sensor were between 0.87 % and 2.17 %, showing its reliability. The successful performance of the sensor in the presence of metabolites belonging to BOR demonstrates its unique selectivity. The selectivity was demonstrated via relative imprinting factor (IF') values (higher than 3.5) against BOR's metabolites. The stability of the CuNFs/AMPS/MIP-GCE sensor was found to be 5 days.
这项工作代表了基于分子印迹聚合物 (MIP) 的电化学传感器在用于测定首个开发的蛋白酶体抑制剂硼替佐米 (BOR) 的灵敏和选择性方面的首次成功应用。BOR 用于治疗多发性骨髓瘤、胃肠道间质瘤和套细胞淋巴瘤。它通过硼酸基团发挥其预期作用,可通过静脉内或皮下给药。基于 MIP 的电化学传感器设计包括整合来自藏红花的绿色合成铜纳米花 (CuNFs) 来自番红花 (Crocus sativus L.),以增加玻碳电极 (GCE) 表面的活性表面积和孔隙率。2-丙烯酰胺基-2-甲基-1-丙磺酸 (AMPS) 被选为功能单体,与其他 MIP 成分一起。使用扫描电子显微镜 (SEM)、X 射线衍射 (XRD)、傅里叶变换红外光谱 (FTIR)、能量色散 X 射线分析 (EDX)、循环伏安法 (CV) 和电化学阻抗谱 (EIS) 对开发的 CuNFs/AMPS/MIP-GCE 传感器和 CuNFs 进行了详细表征。使用 5.0 mM [Fe(CN)]溶液的间接测量方法在 2.5×10-6 M-2.5×10-5 M (0.25-2.5 pM) 的线性范围内测定 BOR。在 fM 水平下获得的传感器的 LOD 和 LOQ 值(29 fM 和 96.7 fM),在相同浓度范围内对商业人血清样品具有线性响应,强调了其灵敏度(29 fM 和 96.7 fM),强调了其灵敏度(29 fM 和 96.7 fM),强调了其灵敏度(29 fM 和 96.7 fM)。在标准溶液和血清中,分别为 1.89×10和 2.14×10μA/M)。传感器的重复性和重现性在 0.87%至 2.17%之间,显示出其可靠性。在存在属于 BOR 的代谢物的情况下,传感器的成功性能证明了其独特的选择性。通过相对印迹因子 (IF') 值(高于 3.5)对 BOR 的代谢物进行了选择性证明。CuNFs/AMPS/MIP-GCE 传感器的稳定性发现为 5 天。